These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 23189963)
1. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience. Fan Y; Lin R; Yang L; Ye L; Yu J; Shu Q Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963 [TBL] [Abstract][Full Text] [Related]
2. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271 [TBL] [Abstract][Full Text] [Related]
3. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694 [TBL] [Abstract][Full Text] [Related]
4. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626 [TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery. Leyvi G; Nelson O; Yedlin A; Pasamba M; Belamarich PF; Nair S; Cohen HW J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):402-6. PubMed ID: 21419653 [TBL] [Abstract][Full Text] [Related]
9. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459 [TBL] [Abstract][Full Text] [Related]
10. Aprotinin in cardiac surgery patients: is the risk worth the benefit? Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574 [TBL] [Abstract][Full Text] [Related]
11. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368 [TBL] [Abstract][Full Text] [Related]
12. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study. Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573 [TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery. Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040 [TBL] [Abstract][Full Text] [Related]
14. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159 [TBL] [Abstract][Full Text] [Related]
15. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Riddell RE; Buth KJ; Sullivan JA Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043 [TBL] [Abstract][Full Text] [Related]
16. Aprotinin is safe in pediatric patients undergoing cardiac surgery. Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656 [TBL] [Abstract][Full Text] [Related]
17. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience. Bojan M; Boulat C; Peperstraete H; Pouard P Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the systems for the identification of postoperative acute kidney injury in pediatric cardiac patients. Lex DJ; Tóth R; Cserép Z; Alexander SI; Breuer T; Sápi E; Szatmári A; Székely E; Gál J; Székely A Ann Thorac Surg; 2014 Jan; 97(1):202-10. PubMed ID: 24206964 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of aprotinin in neonatal congenital heart operations. Wilder NS; Kavarana MN; Voepel-Lewis T; Paugh T; Lee T; Ohye RG Ann Thorac Surg; 2011 Sep; 92(3):958-63. PubMed ID: 21871283 [TBL] [Abstract][Full Text] [Related]